JPRN-UMIN000014917
Completed
N/A
Examination of efficacy and safety of negative pressure wound therapy for surgical wound in ostomy closure - Efficacy of negative pressure wound therapy for wound closure in ostomy site
ConditionsInflammatory bowel disease
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Inflammatory bowel disease
- Sponsor
- Hyogo College of Medicine
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients without agreement of this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 4
Efficacy of pre emptive epidural dexmedetomidine in patients with upper abdominal surgeries under general anaesthesia.CTRI/2019/04/018529MB hospital
Recruiting
N/A
A study to test the advantages of ultrasound guided spinal anesthsia as compared to conventional landmark using spinal anesthesiaHealth Condition 1: null- Patients scheduled for elective surgeries under spinal anesthesiaCTRI/2017/11/010545Armed Forces Medical College
Active, Not Recruiting
N/A
Investigation of the efficacy and safety of preoperative IOP reduction with preservative-free COSOPT-S® (dorzolamide/timolol, MSD) eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma patients - COSOPT-S® StudyPatients with glaucoma requiring trabeculectomy (filtration surgery)MedDRA version: 12.1Level: LLTClassification code 10018304Term: GlaucomaMedDRA version: 12.1Level: LLTClassification code 10050156Term: Glaucoma surgeryEUCTR2010-019975-30-DEniversity Medical Center, Johannes Gutenberg-University Mainz
Recruiting
Phase 1
Examination of the safety and usefulness of preoperative chemotherapy and radiation therapy for locally advanced pancreatic cancer (Phase I / II)JPRN-jRCT1031200325wagawa Tadashi58
Active, Not Recruiting
Phase 1
An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study A” or Study B”) at Risk for Developing Sight-Threatening Choroidal Neovascularisation (CNV) Due to Exudative Age-Related Macular Degeneration (AMD). - Anecortave Acetate Risk Reduction Trial (AART)non-exudative age related macular degeneration (dry AMD)EUCTR2005-001598-93-ESAlcon Research Limited2,500